Enzo Biochem Inc. (ENZ)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-MEDICAL LABORATORIES

60 EXECUTIVE BLVD FARMINGDALE, NY 11735

Enzo Biochem is a life sciences and biotechnology company focused on harnessing biological processes to develop research tools, diagnostics and therapeutics, and a provider of test services, including esoteric tests, to the medical community. Co. has three segments: Enzo Clinical Labs, which provides routine and esoteric clinical laboratory tests or procedures used in general patient care; Enzo Life Sciences, which manufactures, develops and markets products and tools to life sciences, drug development and clinical research customers; and Enzo Therapeutics, which is a biopharmaceutical venture that focuses in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.

Data based on most recent fiscal year report
Market Cap262.339 Million Shares Outstanding46.93 Million Avg Volume320.018 Thousand
1-Yr BETA vs S&P TR1.002 Current Ratio5.0 Quick Ratio4.61
View SEC Filings from ENZ instead.

View recent insider trading info

Funds Holding ENZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ENZ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERLYSKY DOV

0 2020-01-10 0

FISCHER REBECCA J.

  • Director
0 2019-12-30 1

BENCH DAVID CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-23 1

BLANK FABIAN

  • 10% Owner
  • SEE REMARKS
10,280 2019-09-17 1

HARBERT MANAGEMENT CORP

HARBERT DISCOVERY FUND, LP

HARBERT DISCOVERY FUND GP, LLC

HARBERT DISCOVERY CO-INVESTMENT FUND I, LP

HARBERT DISCOVERY CO-INVESTMENT FUND I GP, LLC

HARBERT FUND ADVISORS, INC.

BRYANT JOHN F.

LUCAS KENAN

HARBERT RAYMOND J

  • 10% Owner
5,620,681 2019-08-16 5

LAZAR MELVIN F

  • Director
205,000 2019-08-14 0

RABBANI ELAZAR CHM OF THE BD, CEO AND SEC

  • Officer
  • Director
1,661,003 2019-01-14 0

WEINER BARRY W PRES, CFO PRIN ACCT OFCR TREAS

  • Officer
  • Director
1,136,918 2019-01-14 0

BORTZ GREGORY M.

  • Director
93,699 2019-01-14 0

O'BRIEN JAMES MICHAEL EVP OF FINANCE

  • Officer
0 2019-01-03 0

HANNA BRUCE A.

  • Director
0 2019-01-03 0

GOLDBERG DAVID C CHIEF OPERATING OFFICER

  • Officer
34,051 2017-11-17 0

KRENITSKY KEVIN PRESIDENT

  • Officer
0 2016-06-13 0

KASTEN BERNARD L

  • Director
0 2016-01-06 0

DELUCCA JOHN

  • Director
32,343 2015-03-04 0

BASS HERBERT B VP OF FINANCE

  • Officer
0 2014-01-17 0

CRESCENZO ANDREW R. SENIOR VP OF FINANCE

  • Officer
0 2014-01-17 0

WHITELEY ANDREW P COO, ENZO LIFE SCIENCES, INC.

  • Officer
0 2014-01-17 0

KENT STEPHEN B H

  • Director
0 2012-01-26 0

BALEZENTIS CARL W PRES., ENZO LIFE SCIENCES

  • Officer
25,950 2010-12-15 0

GERSON IRWIN

  • Director
0 2010-03-04 0

RABBANI SHAHRAM K TREASURER, SECRETARY

  • Officer
  • Director
1,539,392 2009-07-01 0

FISCHETTE CHRISTINE PRES., ENZO THERAPEUTICS, INC.

  • Officer
11,500 2009-01-22 0

SIAS JOHN B

  • Director
173,087 2008-09-26 0

KELKER NORMAN E SENIOR VICE PRESIDENT

  • Officer
110,855 2008-09-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments